Alzheimer risk-increasing TREM2 variant causes aberrant cortical synapse density and promotes network hyperexcitability in mouse models

Neurobiol Dis. 2023 Oct 1:186:106263. doi: 10.1016/j.nbd.2023.106263. Epub 2023 Aug 15.

Abstract

The R47H variant of triggering receptor expressed on myeloid cells 2 (TREM2) increases the risk of Alzheimer's disease (AD). To investigate potential mechanisms, we analyzed knockin mice expressing human TREM2-R47H from one mutant mouse Trem2 allele. TREM2-R47H mice showed increased seizure activity in response to an acute excitotoxin challenge, compared to wildtype controls or knockin mice expressing the common variant of human TREM2. TREM2-R47H also increased spontaneous thalamocortical epileptiform activity in App knockin mice expressing amyloid precursor proteins bearing autosomal dominant AD mutations and a humanized amyloid-β sequence. In mice with or without such App modifications, TREM2-R47H increased the density of putative synapses in cortical regions without amyloid plaques. TREM2-R47H did not affect synaptic density in hippocampal regions with or without plaques. We conclude that TREM2-R47H increases AD-related network hyperexcitability and that it may do so, at least in part, by causing an imbalance in synaptic densities across brain regions.

Keywords: Alzheimer's disease; Amyloid precursor protein; EEG; Epilepsy; Glia; Hyperexcitability; Microglia; Network dysfunction; Synapses; TREM2.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Alzheimer Disease* / genetics
  • Amyloid beta-Peptides
  • Animals
  • Disease Models, Animal
  • Humans
  • Membrane Glycoproteins / genetics
  • Mice
  • Plaque, Amyloid
  • Receptors, Immunologic / genetics
  • Seizures
  • Synapses

Substances

  • Amyloid beta-Peptides
  • TREM2 protein, human
  • Membrane Glycoproteins
  • Receptors, Immunologic
  • Trem2 protein, mouse